Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
Clinical trial NCT00694304 · COMPLETED
Trial details
- NCT number
- NCT00694304
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-03-01
- Enrollment
- 535
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.